Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
| Metric | Sep 21 | Sep 22 | Sep 23 | Sep 24 | Sep 25 |
|---|---|---|---|---|---|
| Revenue | 97 | 86↓11.2% | 79↓8.1% | 68↓14.6% | 65↓3.4% |
| Gross Profit | 97 | 86↓11.2% | 79↓8.1% | 68↓14.6% | 65↓3.4% |
| Operating Income | -110 | -124↓13.0% | -137↓10.8% | -122↑11.3% | -85↑29.9% |
| Net Income | -79 | -122↓54.1% | -134↓9.9% | -116↑13.3% | -82↑29.4% |
| EBITDA | -104 | -119↓14.4% | -123↓3.6% | -105↑15.4% | -71↑32.3% |
| EPS Diluted | -3.92 | -5.91↓50.8% | -6.38↓8.0% | -5.48↑14.1% | -3.84↑29.9% |